GLP-1/ GIP weight loss drugs sold under the brand names like Wegovy/Ozempic, Mounjaro/Zepbound, Saxenda/Victoza have become highly popular because they represent a breakthrough in obesity treatment
Protein needs can vary based on body weight, activity level, age, and overall goals
These include dietary choices (such as asparagus, coffee, or certain spices), hydration status, vitamin supplements, and underlying metabolic changes
Without coverage, the decision tilts toward manufacturer cash programs, the patient-specific compounded tirzepatide path, or the research market based on individual risk tolerance and ability to verify quality
The white paper states that the lack of regulatory enforcement surrounding off-brand GLP-1s poses a safety risk for people who use them, citing multiple cases of safety concerns tied to compounded or counterfeit GLP-1s